Page last updated: 2024-12-05

2-tert-butyl-4-hydroxyanisole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-tert-butyl-4-hydroxyanisole : An aromatic ether that is 4-methoxyphenol in which one of the hydrogens ortho- to the methoxy group is replaced by a tert-butyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6932
CHEBI ID76357
SCHEMBL ID61547
MeSH IDM0146219

Synonyms (47)

Synonym
phenol, 3-(1,1-dimethylethyl)-4-methoxy-
phenol, 3-tert-butyl-4-methoxy-
2-tert-butyl-4-hydroxyanisole
brn 2209222
ccris 3606
einecs 201-820-3
3-butyl-4-hydroxyanisole
3-tert-butyl-4-methoxyphenol
AC-10352
88-32-4
2-bha
FT-0664169
AKOS006274867
3-tert-butyl-4-methoxy-phenol
2-tert-butyl-4-hydroxy anisole
3-(tert-butyl)-4-methoxyphenol
bdbm50377940
unii-a03ij8roop
a03ij8roop ,
2-(1,1-dimethylethyl)-4-hydroxyanisole
3-(1,1-dimethylethyl)-4-methoxyphenol
2-tert-butyl-p-hydroxyanisole
4-methoxy-3-tert-butylphenol
4-methoxy-3-tert-butyl-phenol
8003-24-5
SCHEMBL61547
m-tert-butyl-p-methoxyphenol
p-methoxy-m-tert-butylphenol
4-methoxy-5-tert-butylphenol
4-hydroxy-2-tert-butylanisole
CHEBI:76357
MB00490
2-tert-butyl-4-hydroxyanisole [usp-rs]
tert-butyl-hydroquinone monomethyl ether
DTXSID7058963
t-butyl-4-hydroxyanisole
3-t-butyl-4-methoxyphenol
tbmp
mfcd00057667
DS-17538
AMY28195
CS-0060876
W17039
EN300-3212116
SY316299
HY-W024365
Z1198149489
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (40.00)18.7374
1990's5 (33.33)18.2507
2000's3 (20.00)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.65 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.23 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]